Patents Assigned to Metabolic Solutions Development Company
  • Patent number: 8304441
    Abstract: The present invention relates to thiazolidinedione analogues that are useful for treating hypertension, diabetes, and inflammatory diseases.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: November 6, 2012
    Assignee: Metabolic Solutions Development Company, LLC
    Inventors: Gerard R. Colca, Robert C. Gadwood, Tim Parker
  • Publication number: 20120129896
    Abstract: The present invention relates to thiazolidinedione analogues that are useful for treating hypertension, diabetes, and inflammatory diseases.
    Type: Application
    Filed: November 16, 2011
    Publication date: May 24, 2012
    Applicant: Metabolic Solutions Development Company
    Inventors: Gerard R. Colca, Robert C. Gadwood, Tim Parker
  • Publication number: 20120015982
    Abstract: The present invention relates to thiazolidinedione analogues that are useful for treating metabolic inflammation mediated diseases such as diabetes.
    Type: Application
    Filed: May 18, 2011
    Publication date: January 19, 2012
    Applicant: Metabolic Solutions Development Company
    Inventors: Gerard R. Colca, Rolf F. Kletzien
  • Patent number: 8067450
    Abstract: The present invention relates to thiazolidinedione analogues that are useful for treating hypertension, diabetes, and inflammatory diseases. Formula (I), wherein: each of R1 and R4 is independently selected from H, halo, aliphatic, and alkoxy, wherein the aliphatic and alkoxy are optionally substituted with 1-3 of halo; R2 is halo, hydroxy, or optionally substituted aliphatic, and R?2 is H, or R2 and R?2 together form oxo; R3 is H; and Ring A is a phenyl.
    Type: Grant
    Filed: September 15, 2008
    Date of Patent: November 29, 2011
    Assignee: Metabolic Solutions Development Company
    Inventors: Gerard R. Colca, Robert C. Gadwood, Tim Parker